TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET 23
1.4 LIMITATIONS 25
1.5 MARKETS COVERED 25
2 MARKET SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 28
2.4 CURRENCY AND PRICING 28
2.5 DBMR TRIPOD DATA VALIDATION MODEL 29
2.6 MULTIVARIATE MODELLING 32
2.7 PRODUCTS LIFELINE CURVE 32
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 33
2.9 DBMR MARKET POSITION GRID 34
2.10 MARKET APPLICATION COVERAGE GRID 35
2.11 VENDOR SHARE ANALYSIS 36
2.12 SECONDARY SOURCES 37
2.13 ASSUMPTIONS 37
3 EXECUTIVE SUMMARY 38
4 PRIMIUM INSIGHT 40
4.1 PESTEL 41
4.2 PORTER 42
5 VALUE CHAIN ANALYSIS 43
6 INDUSTRY INSIGHTS 44
6.1 MICRO AND MACROECONOMIC FACTORS 44
6.2 PENETRATION AND GROWTH PROSPECT MAPPING 44
6.3 KEY PRICING STRATEGIES 45
7 COST ANALYSIS BREAKDOWN 46
8 TECHNOLOGY ROADMAP 47
9 REIMBURSEMENT FRAMEWORK 49
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS 50
11 REGULATION 51
12 MARKET OVERVIEW 52
12.1 DRIVERS 53
12.1.1 INCREASE IN THE GERIATRIC POPULATION 53
12.1.2 RISE IN INCIDENCE OF GLAUCOMA 54
12.1.3 GROWTH IN THE POPULARITY OF MINIMALLY INVASIVE SURGERY 54
12.2 RESTRAINTS 54
12.2.1 INADEQUATE REIMBURSEMENT SCENARIO 54
12.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES 55
12.3 OPPORTUNITIES 56
12.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES 56
12.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT 56
12.4 CHALLENGES 57
12.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE 57
12.4.2 RISKS ASSOCIATED WITH MICRO INVASIVE GLAUCOMA SURGERY 57
13 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE 58
13.1 OVERVIEW 59
13.2 MIGS STENTS 62
13.3 MIGS SHUNTS 62
13.4 TRABECTOME 62
13.5 KAHOOK DUAL BLADE 62
13.6 TUBE SHUNT 62
13.7 MICRO IMPLANTS 63
13.8 MICRO CATHETERS 63
13.9 OTHERS 63
14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET 64
14.1 OVERVIEW 65
14.2 TRABECULAR MESHWORK 67
14.3 REDUCING AQUEOUS PRODUCTION 67
14.4 SUPRACHOROIDAL SPACE 68
14.5 SUBCONJUNCTIVAL FILTRATION 68
14.6 OTHERS 68
15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE 69
15.1 OVERVIEW 70
15.2 GLAUCOMA IN CONJUNCTION WITH CATARACT 72
15.3 STAND-ALONE GLAUCOMA 72
16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE 73
16.1 OVERVIEW 74
16.2 OPEN ANGLE GLAUCOMA 76
16.3 ACUTE ANGLE GLAUCOMA 76
16.4 NORMAL TENSION GLAUCOMA 76
16.5 SECONDARY GLAUCOMA 76
16.6 PIGMENTARY GLAUCOMA 76
16.7 CONGENITAL GLAUCOMA 77
17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER 78
17.1 OVERVIEW 79
17.2 HOSPITAL OUTPATIENT DEPARTMENT (HOPD) 82
17.3 OPHTHALMOLOGY CLINICS 82
17.4 AMBULATORY SURGERY CENTERS (ASCS) 82
17.5 OTHERS 82
18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL 83
18.1 OVERVIEW 84
18.2 DIRECT TENDER 86
18.3 RETAIL SALES 86
18.4 OTHERS 86
19 EUROPE 88
19.1 GERMANY 96
19.2 U.K. 102
19.3 FRANCE 108
19.4 ITALY 114
19.5 RUSSIA 120
19.6 SPAIN 126
19.7 TURKEY 132
19.8 SWITZERLAND 138
19.9 NETHERLANDS 144
19.10 BELGIUM 150
19.11 DENMARK 156
19.12 POLAND 162
19.13 SWEDEN 168
19.14 NORWAY 174
19.15 FINLAND 180
19.16 REST OF EUROPE 186
20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE 187
20.1 COMPANY SHARE ANALYSIS: EUROPE 187
21 SWOT ANALYSIS 188
22 QUESTIONNAIRE 189
23 RELATED REPORTS 192

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.